The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Carlsmed sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Carlsmed is a medical technology company that provides patient imaging, clinical algorithms, and 3D printing technologies that are used to create personalized implants and surgical plans. It uses patient data and digital technologies to create optimal surgical plans and personalized aprevo spine fusion devices to improve outcomes and decrease the cost of healthcare for spine surgery. The company’s key solution, aprevo is a spine fusion device and digital-to-device 3-D printed implant system that is used for the treatment of lumbar spine surgery. Carlsmed is headquartered in Carlsbad, California, the US.
The key metrics of Carlsmed related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Carlsmed is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Carlsmed.
For a detailed understanding of the performance of Carlsmed, buy the report here.